UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,000 | -30.8% | 22,620 | 0.0% | 0.00% | – |
Q2 2022 | $13,000 | -48.0% | 22,620 | 0.0% | 0.00% | – |
Q1 2022 | $25,000 | -24.2% | 22,620 | 0.0% | 0.00% | – |
Q4 2021 | $33,000 | -69.7% | 22,620 | -38.1% | 0.00% | – |
Q3 2021 | $109,000 | -35.5% | 36,523 | +0.4% | 0.00% | – |
Q2 2021 | $169,000 | -73.3% | 36,393 | -65.5% | 0.00% | – |
Q1 2021 | $633,000 | +5.0% | 105,539 | -8.4% | 0.00% | – |
Q4 2020 | $603,000 | +99.7% | 115,189 | +31.7% | 0.00% | – |
Q3 2020 | $302,000 | -60.1% | 87,440 | +0.5% | 0.00% | – |
Q2 2020 | $756,000 | +62.6% | 87,003 | +8.5% | 0.00% | – |
Q1 2020 | $465,000 | -16.1% | 80,212 | +4.5% | 0.00% | – |
Q4 2019 | $554,000 | +37.8% | 76,762 | +16.7% | 0.00% | – |
Q3 2019 | $402,000 | -39.1% | 65,753 | -5.4% | 0.00% | – |
Q2 2019 | $660,000 | +28.4% | 69,516 | +9.6% | 0.00% | – |
Q1 2019 | $514,000 | -46.1% | 63,404 | +8.2% | 0.00% | – |
Q4 2018 | $953,000 | +272.3% | 58,620 | +273.3% | 0.00% | – |
Q3 2018 | $256,000 | +52.4% | 15,705 | +40.6% | 0.00% | – |
Q2 2018 | $168,000 | – | 11,173 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |